Coloplast A/S (XSWX:COLOB)
CHF 115 0 (0%) Market Cap: 22.64 Bil Enterprise Value: 25.50 Bil PE Ratio: 40.61 PB Ratio: 11.45 GF Score: 91/100

Q1 2023 Coloplast A/S Earnings Call Transcript

Feb 03, 2023 / 10:00AM GMT
Release Date Price: CHF115
Operator

Good morning, ladies and gentlemen. Thank you for standing by. Welcome, and thank you for joining the Coloplast's Q1 2022/'23 Earnings Release Conference Call. (Operator Instructions)

It's my pleasure, and I would now like to turn the conference over to Kristian Villumsen, President and CEO. Please go ahead, sir.

Kristian Villumsen;S;President;CEO
Coloplast A

/-&

Good morning, and welcome to our Q1 '22/'23 conference call. I'm Kristian Villumsen, CEO of Coloplast, and I'm joined by our CFO, Anders Lonning-Skovgaard and our investor Relations team. We'll start with a short presentation by Anders and myself and then open up for questions like we usually do.

Please turn to Slide #3. We delivered 7% organic growth and a 29% EBIT margin before special items. Return on invested capital after tax and before special items was 20%, impacted by the Atos Medical acquisition. I'm satisfied with the solid start to the year. We continue to outgrow the market across regions and help more people with

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot